Trusted Resources: Education
Scientific literature and patient education texts
Corneal Cloudiness: A Presenting Feature of Mucopolysaccharidosis Type I
source: Indian journal of pediatrics
year: 2021
authors: Khurana S,Gupta PC,Behera RK,Singh H,Ram J
summary/abstract:A 10-y-old ‘short-statured’ male presented to us with decreased vision in both the eyes since birth. Ocular examination revealed cloudy corneas in both the eyes (Fig. 1a, b). Family history was unremarkable. Suspecting it to be mucopolysaccharidosis, the child was referred to a pediatrician. Systemic examination revealed global developmental delay, short stature, abdominal distension, umbilical hernia, and hepatosplenomegaly with dysmorphic facial features like frontal bossing, saddle nose, wide mouth, and macroglossia. As the patient had frank corneal clouding, skeletal dysplasia, umbilical hernia, and intellectual impairment, he was most likely to have mucopolysaccharidosis type I, Hurler syndrome. The child was planned for sequential penetrating keratoplasty. For the disorder, the option of enzyme replacement therapy was discussed with the parents, but could not be materialized because of financial constraints.
organization: Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.DOI: 10.1007/s12098-021-03855-w
read more
Related Content
-
Extraordinary Experiences ProgramProgram provides grants of up to $1000 t...
-
Fetal Therapies and Trials for Lysosomal Storage Diseases: A Survey of Attitudes of Parents and PatientsLysosomal storage diseases (LSDs) are in...
-
Proposal of An Algorithm to Early Detect Attenuated Type I Mucopolysaccharidosis (MPS IA) Among Children With Growth...Diagnostic delay is common in attenuated...
-
Damage of the Cardiovascular System in Lysosomal Storage Disease – MucopolysaccharidosisThe analysis of literature data reflecti...
-
Trigger Finger in Children With Hurler Syndrome – Distribution Pattern and Treatment OptionsMucopolysaccharidosis is a rare and cong...
-
MPS 1: Where Are We NowDr. Sandra Kingma from the Centre for Ra...
-
Mucopolysaccharidoses (MPS) and Gene TherapyMucopolysaccharidoses (MPS) are a group ...